NOT-HL-16-450: Notice of Availability of Frequently Asked Questions for PAR-16-405 "Single-Site Investigator-Initiated Clinical Trials (R61/R33)"

Notice of Availability of Frequently Asked Questions for PAR-16-405 "Single-Site Investigator-Initiated Clinical Trials (R61/R33)"

Notice Number: NOT-HL-16-450

Key Dates
Release Date: September 19, 2016

Related Announcements
PAR-16-405
NOT-HL-16-336

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice to inform potential applicants that NHLBI has posted a set of answers to Frequently Asked Questions (FAQs) regarding application for PAR-16-405 "Single-Site Investigator-Initiated Clinical Trials (R61/R33)".

The Frequently Asked Questions are available at this site:

PAR-16-405 Frequently Asked Questions

In addition, information on NHLBI Research Support Mechanisms for Clinical Trials is available at:

NHLBI Research Support Mechanisms Guidelines and Descriptions

While not required, all applicants are encouraged to view the FAQs prior to submitting their application.

Inquiries

Please direct all inquiries to:

Email: [email protected]